When was Clario founded?

Clario was founded in 1972 and raised its 1st funding round 40 years after it was founded.

Where is Clario located?

Clario is headquartered in Philadelphia, United States.

How many employees does Clario have?

As of Apr 30, 2026, the latest employee count at Clario is 7109.

Is Clario a funded company?

Clario is a funded company, having raised a total of $***** in its 1st and only funding round, a Grant (prize money) round on Jun 21, 2012.

When was the latest funding round of Clario?

Clario's latest funding was a $***** Grant (prize money) round on Jun 21, 2012, with participation from 1 investor.

Where does Clario rank among its competitors?

Clario ranks 2nd amongst 217 active competitors, of which 14 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was N-Power Medicine, which secured an undisclosed amount in Jul, 2024.

Who are the top competitors of Clario?

Clario's top competitors include Cognivia, N-Power Medicine and CRYOPDP. Among them, N-Power Medicine secured the most recent funding round in July, 2024.

Clario - 2026 Company Profile, Funding & Competitors

Company Details

Website: www.clario.com
Social
Email ID: *****@clario.com
Phone Number: +1 **********

Key Metrics

Founded Year

1972

Location

Philadelphia, United States

Stage

Acquired

Latest Funding Round

Grant (prize money), Jun 21, 2012, $*****

Investors

ATP Private Equity Partners & 8 more

Ranked

2^nd among 217 active competitors

Employee Count

7,109 as on Apr 30, 2026

Investment & Acquisitions

NeuroRx & 20 more

Similar Companies

Cognivia & 237 more

Exit Details

Acquired by Thermo Fisher Scientific (Nov 05, 2025)

View Clario's full profile

Clario is associated with 5 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
CLINICAL TRIALS TECHNOLOGY INC CIN: 481221023 , United States, Active	Dec 31, 1999	-	11 (As on Dec 31, 2014)	-
SYNARC LTD. CIN: 7794874 , United Kingdom, Active	Oct 02, 2011	$6.98M (As on Dec 31, 2024)	61 (As on Dec 31, 2024)
QINECSA SOLUTIONS INDIA PRIVATE LIMITED CIN: U72200KA2008FTC048542 , India, Active	Dec 08, 2008	$19.6M (As on Mar 31, 2025)	-
U S BIOMEDICAL SYSTEMS INDIA PRIVATE LIMITED CIN: U74900PY2009PTC002396 , India, Active	Dec 22, 2009	$18.3M (As on Mar 31, 2025)	720 (As on Jul 31, 2024)
BioClinica, Inc CIN: 202821681 , United States, Active		-	697 (As on Dec 31, 2019)	-

Clario got acquired by Thermo Fisher Scientific on Nov 05, 2025 at an acquisition amount of $*****.

Click here to take a look at Clario's acquisition in detail

Clario has raised funding over 1 round. Its latest funding round was a Grant (prize money) round on Jun 21, 2012 for $*****. 1 investor participated in its latest round. Clario has 9 institutional investors.

Here is the list of recent funding rounds of Clario:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 21, 2012	3335419	Grant (prize money)	2837080	2787032	4809846	4584320

Access funding benchmarks and valuations. Sign up today!

View details of Clario's funding rounds and investors

Clario's employee count trend

Clario has 7,109 employees as of Apr 26. Here is Clario's employee count trend over the years:

Uncover Clario's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Clario include Cognivia, N-Power Medicine and CRYOPDP. Here is the list of Top 10 competitors of Clario, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Cognivia 2013, Mont Saint Guibert (Belgium), Series B	Provider of data modeling and patient insights for clinical trial optimization	$16.5M	Wallonie Entreprendre, Vesalius Biocapital Partners ... & 2 others	52/100
2nd	Clario 1972, Philadelphia (United States), Acquired	CRO focused on providing clinical trial supply services for biopharma sector	-	ATP Private Equity Partners, Athyrium Capital Management ... & 7 others	50/100
3rd	N-Power Medicine 2021, Redwood City (United States), Series B	Provider of clinical trial services	$72M	Merck Global Health Innovation Fund	48/100
4th	CRYOPDP 1992, Tremblay-en-France (France), Acquired	Provider of cold chain clinical trial logistics services	-	-	47/100
5th	Dr. Vince Clinical Research 2021, Overland Park (United States), Unfunded	CRO focused on clinical trial development services	-	-	43/100
6th	SFJ Pharmaceuticals 2008, Pleasanton (United States), Late Stage	Specialty pharmaceutical company based on partnering model	$69.5M	Abingworth, Blackstone	42/100
7th	PCM Trials 2008, Denver (United States), Unfunded	Provider of research and decentralized clinical trials	-	-	40/100
8th	Myonex 2020, Norristown (United States), Unfunded	CRO focused on providing clinical trial supply solutions	-	-	39/100
9th	Medsir 2012, Barcelona (Spain), Unfunded	Clinical research organization specializing in the design and management of strategic clinical trials in oncology	-	-	39/100
10th	Ikris Pharma Network 2014, Noida (India), Unfunded	Provider of clinical trial sourcing services	-	-	39/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Clario's competitors? Click here to see the top ones

Clario has not made any investments yet. Clario has made 21 acquisitions.

Here is the list of latest three $acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Mar 17, 2025	Acquisition	NeuroRx	2003	Montreal (Canada)
Apr 02, 2024	Acquisition	ArtiQ	2019	Leuven (Belgium)
Apr 06, 2022	Acquisition	My Meds & Me	2012	London (United Kingdom)